Acasti Pharma Inc (ACST: NASDAQ)
$1.95 0.04 | 2.09%
11/01/13 - 03:58 PM ET
TheStreet Ratings Grade for ACST
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings data is not available for ACST.
Portfolios with ACST
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
Latest ACST Headlines from TheStreet
- Acasti Announces Closing Of US$23 Million Underwritten Offering Of Units 12.03.13 | 10:12 am
- Acasti Announces Pricing Of US$20 Million Offering Of Units 11.27.13 | 09:11 am
- Acasti Announces Proposed Offering Of Units 11.26.13 | 04:11 pm
- Acasti Completes PK IND Submission 11.11.13 | 08:11 am
- Reed V. Tuckson, M.D. Joins Acasti's Board Of Directors 11.05.13 | 08:11 am
- Acasti Strengthens Its IP Portfolio 10.29.13 | 08:10 am
- Acasti Announces Second Quarter Results 10.15.13 | 08:10 am
- Acasti Announces Positive Phase II Open Label Clinical Trial Results 08.13.13 | 08:08 am
- Acasti Signs Manufacturing Agreement 07.31.13 | 08:07 am
- Acasti Announces First Quarter Results 07.15.13 | 08:07 am
Press Releases for ACST
Partner Headlines for ACST
- Acasti Prices 16M Unit Offering at $1.25/Unit - Benzinga 11.27.13 | 09:11 am